Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD

Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

(2017) S. Bakchine et al.   JOURNAL OF ALZHEIMERS DISEASE

Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative

(2011) Lon S. Schneider   ARCHIVES OF NEUROLOGY

Memantine in dementia: a review of the current evidence

(2011) Nathan Herrmann et al.   EXPERT OPINION ON PHARMACOTHERAPY

Early Alzheimer's Disease

(2010) Richard Mayeux   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s Disease

(2009) David Wilkinson et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research

Pharmacodynamics of Memantine: An Update

(2008) C. Parsons et al.   Current Neuropharmacology

Alzheimer's disease in real life – the dementia carer's survey

(2008) Jean Georges et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY